189 related articles for article (PubMed ID: 10722520)
1. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.
Zhanel GG; Karlowsky JA; Harding GK; Carrie A; Mazzulli T; Low DE; Hoban DJ
Antimicrob Agents Chemother; 2000 Apr; 44(4):1089-92. PubMed ID: 10722520
[TBL] [Abstract][Full Text] [Related]
2. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
[TBL] [Abstract][Full Text] [Related]
3. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.
Karlowsky JA; Kelly LJ; Thornsberry C; Jones ME; Sahm DF
Antimicrob Agents Chemother; 2002 Aug; 46(8):2540-5. PubMed ID: 12121930
[TBL] [Abstract][Full Text] [Related]
4. High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.
Arredondo-García JL; Amábile-Cuevas CF
J Infect Dev Ctries; 2008 Oct; 2(5):350-3. PubMed ID: 19745501
[TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010.
Sanchez GV; Master RN; Karlowsky JA; Bordon JM
Antimicrob Agents Chemother; 2012 Apr; 56(4):2181-3. PubMed ID: 22252813
[TBL] [Abstract][Full Text] [Related]
6. Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients.
McGregor JC; Elman MR; Bearden DT; Smith DH
BMC Fam Pract; 2013 Feb; 14():25. PubMed ID: 23433241
[TBL] [Abstract][Full Text] [Related]
7. Development of antibacterial resistance: the Dutch experience.
Beunders AJ
J Antimicrob Chemother; 1994 May; 33 Suppl A():17-22. PubMed ID: 7928833
[TBL] [Abstract][Full Text] [Related]
8. Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands.
Goettsch W; van Pelt W; Nagelkerke N; Hendrix MG; Buiting AG; Petit PL; Sabbe LJ; van Griethuysen AJ; de Neeling AJ
J Antimicrob Chemother; 2000 Aug; 46(2):223-8. PubMed ID: 10933644
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
Karlowsky JA; Hoban DJ; Decorby MR; Laing NM; Zhanel GG
Antimicrob Agents Chemother; 2006 Jun; 50(6):2251-4. PubMed ID: 16723598
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic activity in microbiological media versus that in human urine: comparison of ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole.
Drobot GR; Karlowsky JA; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 1996 Jan; 40(1):237-40. PubMed ID: 8787914
[TBL] [Abstract][Full Text] [Related]
12. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM
J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
[TBL] [Abstract][Full Text] [Related]
13. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
Bailey RR; Peddie BA
N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
[No Abstract] [Full Text] [Related]
14. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
[TBL] [Abstract][Full Text] [Related]
15. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15.
Delisle G; Quach C; Domingo MC; Boudreault AA; Gourdeau M; Bernatchez H; Lavallée C
J Antimicrob Chemother; 2016 Dec; 71(12):3562-3567. PubMed ID: 27494927
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study.
Karlowsky JA; Lagacé-Wiens PR; Simner PJ; DeCorby MR; Adam HJ; Walkty A; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2011 Jul; 55(7):3169-75. PubMed ID: 21537027
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics.
Hirsch EB; Zucchi PC; Chen A; Raux BR; Kirby JE; McCoy C; Eliopoulos GM
Antimicrob Agents Chemother; 2016 May; 60(5):3138-40. PubMed ID: 26883704
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections.
Olson RP; Harrell LJ; Kaye KS
Antimicrob Agents Chemother; 2009 Mar; 53(3):1285-6. PubMed ID: 19104022
[TBL] [Abstract][Full Text] [Related]
19. Five-year survey of changing patterns of susceptibility of bacterial uropathogens to trimethoprim-sulfamethoxazole and other antimicrobial agents.
Alon U; Davidai G; Berant M; Merzbach D
Antimicrob Agents Chemother; 1987 Jan; 31(1):126-8. PubMed ID: 3551824
[TBL] [Abstract][Full Text] [Related]
20. High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread.
Poulsen HO; Johansson A; Granholm S; Kahlmeter G; Sundqvist M
J Antimicrob Chemother; 2013 Sep; 68(9):1974-7. PubMed ID: 23640126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
